Your browser doesn't support javascript.
loading
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from the GMMG-HD6 and -HD7 trials.
Kauer, Joseph; Freundt, Emma P; Schmitt, Anita; Weinhold, Niels; Mai, Elias K; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Raab, Marc S; Kriegsmann, Katharina; Sauer, Sandra.
Afiliación
  • Kauer J; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Freundt EP; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
  • Schmitt A; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Weinhold N; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Mai EK; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Müller-Tidow C; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Goldschmidt H; GMMG Study Group at University Hospital Heidelberg, Heidelberg, Germany.
  • Raab MS; Department of Haematology, Oncology and Rheumatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.
  • Kriegsmann K; Molecular Medicine Partnership Unit (MMPU), Heidelberg, Germany.
  • Sauer S; National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
BMC Cancer ; 23(1): 1132, 2023 Nov 21.
Article en En | MEDLINE | ID: mdl-37990162

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre de Sangre Periférica / Compuestos Heterocíclicos / Mieloma Múltiple Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre de Sangre Periférica / Compuestos Heterocíclicos / Mieloma Múltiple Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Alemania